相关实验视频

Updated: Sep 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

通过实施故障模式和效应分析,优化结直肠癌查计划

María Martínez Burgos¹, Javier Villena-Salinas², Senador Morán Sánchez³

¹Aparato Digestivo, Hospital General Universitario Santa Lucía , España.

Revista espanola de enfermedades digestivas

|June 27, 2025

概括

这项研究使用失效模式和效应分析 (FMEA) 来识别结直肠癌 (CRC) 查中的高风险错误,从而提出了改善患者安全和查质量的策略.

科学领域:

胃肠病学胃肠病学
医疗风险管理医疗风险管理
公共卫生查公共卫生查

背景情况:

结肠直肠癌 (CRC) 查对于早期检测和治疗至关重要.
患者参与CRC查提供了好处,但也带有潜在的风险.
积极主动地管理这些风险对于计划的成功至关重要.

研究的目的:

在CRC选过程中识别潜在的故障模式和高风险错误.
应用风险管理策略以提高患者安全.
提高CRC查计划的整体质量和有效性.

主要方法:

使用故障模式和效应分析 (FMEA) 的单一中心描述性研究.
通过人员头脑风暴确定了故障模式,并根据优先级风险号码 (PRN) 分类.
开发了一个风险矩阵,以优先考虑高风险错误的预防和纠正行动.

主要成果:

确定了12种故障模式,其中4种被归类为高风险 (PRN > 15).
关键的高风险错误包括清洁剂的选择 (PRN=18),病变识别 (PRN=24),镇静 (PRN=16) 和样本识别 (PRN=16).
拟议的缓解策略包括加强员工培训,团队升级,经验丰富的人员分配和标本识别协议.

结论:

FMEA有效地发现了CRC查中的关键错误.
实施的措施旨在减轻已识别的风险,从而提高患者的安全.
该研究强调了FMEA在提高CRC查过程的安全性和质量的价值.

更多相关视频

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...